193 related articles for article (PubMed ID: 25785478)
1. Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities.
Witschel MC; Rottmann M; Schwab A; Leartsakulpanich U; Chitnumsub P; Seet M; Tonazzi S; Schwertz G; Stelzer F; Mietzner T; McNamara C; Thater F; Freymond C; Jaruwat A; Pinthong C; Riangrungroj P; Oufir M; Hamburger M; Mäser P; Sanz-Alonso LM; Charman S; Wittlin S; Yuthavong Y; Chaiyen P; Diederich F
J Med Chem; 2015 Apr; 58(7):3117-30. PubMed ID: 25785478
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial Inhibitors Targeting Serine Hydroxymethyltransferase (SHMT) with in Vivo Efficacy and Analysis of their Binding Mode Based on X-ray Cocrystal Structures.
Schwertz G; Witschel MC; Rottmann M; Bonnert R; Leartsakulpanich U; Chitnumsub P; Jaruwat A; Ittarat W; Schäfer A; Aponte RA; Charman SA; White KL; Kundu A; Sadhukhan S; Lloyd M; Freiberg GM; Srikumaran M; Siggel M; Zwyssig A; Chaiyen P; Diederich F
J Med Chem; 2017 Jun; 60(12):4840-4860. PubMed ID: 28537728
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium serine hydroxymethyltransferase as a potential anti-malarial target: inhibition studies using improved methods for enzyme production and assay.
Sopitthummakhun K; Thongpanchang C; Vilaivan T; Yuthavong Y; Chaiyen P; Leartsakulpanich U
Malar J; 2012 Jun; 11():194. PubMed ID: 22691309
[TBL] [Abstract][Full Text] [Related]
4. Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold.
Schwertz G; Witschel MC; Rottmann M; Leartsakulpanich U; Chitnumsub P; Jaruwat A; Amornwatcharapong W; Ittarat W; Schäfer A; Aponte RA; Trapp N; Chaiyen P; Diederich F
ChemMedChem; 2018 May; 13(9):931-943. PubMed ID: 29655285
[TBL] [Abstract][Full Text] [Related]
5. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
6. Catalytic and ligand-binding characteristics of Plasmodium falciparum serine hydroxymethyltransferase.
Pang CK; Hunter JH; Gujjar R; Podutoori R; Bowman J; Mudeppa DG; Rathod PK
Mol Biochem Parasitol; 2009 Nov; 168(1):74-83. PubMed ID: 19591883
[TBL] [Abstract][Full Text] [Related]
7. A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
Le Manach C; Paquet T; Brunschwig C; Njoroge M; Han Z; Gonzàlez Cabrera D; Bashyam S; Dhinakaran R; Taylor D; Reader J; Botha M; Churchyard A; Lauterbach S; Coetzer TL; Birkholtz LM; Meister S; Winzeler EA; Waterson D; Witty MJ; Wittlin S; Jiménez-Díaz MB; Santos Martínez M; Ferrer S; Angulo-Barturen I; Street LJ; Chibale K
J Med Chem; 2015 Nov; 58(21):8713-22. PubMed ID: 26502160
[TBL] [Abstract][Full Text] [Related]
8. Structures of Plasmodium vivax serine hydroxymethyltransferase: implications for ligand-binding specificity and functional control.
Chitnumsub P; Jaruwat A; Riangrungroj P; Ittarat W; Noytanom K; Oonanant W; Vanichthanankul J; Chuankhayan P; Maenpuen S; Chen CJ; Chaiyen P; Yuthavong Y; Leartsakulpanich U
Acta Crystallogr D Biol Crystallogr; 2014 Dec; 70(Pt 12):3177-86. PubMed ID: 25478836
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases.
Hocková D; Keough DT; Janeba Z; Wang TH; de Jersey J; Guddat LW
J Med Chem; 2012 Jul; 55(13):6209-23. PubMed ID: 22725979
[TBL] [Abstract][Full Text] [Related]
10. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
Malmquist NA; Sundriyal S; Caron J; Chen P; Witkowski B; Menard D; Suwanarusk R; Renia L; Nosten F; Jiménez-Díaz MB; Angulo-Barturen I; Santos Martínez M; Ferrer S; Sanz LM; Gamo FJ; Wittlin S; Duffy S; Avery VM; Ruecker A; Delves MJ; Sinden RE; Fuchter MJ; Scherf A
Antimicrob Agents Chemother; 2015 Feb; 59(2):950-9. PubMed ID: 25421480
[TBL] [Abstract][Full Text] [Related]
11. Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: implications for selective inhibition.
Pinthong C; Maenpuen S; Amornwatcharapong W; Yuthavong Y; Leartsakulpanich U; Chaiyen P
FEBS J; 2014 Jun; 281(11):2570-83. PubMed ID: 24698160
[TBL] [Abstract][Full Text] [Related]
12. Human and Plasmodium serine hydroxymethyltransferases differ in rate-limiting steps and pH-dependent substrate inhibition behavior.
Amornwatcharapong W; Maenpuen S; Chitnumsub P; Leartsakulpanich U; Chaiyen P
Arch Biochem Biophys; 2017 Sep; 630():91-100. PubMed ID: 28760597
[TBL] [Abstract][Full Text] [Related]
13. Serine hydroxymethyltransferase from Plasmodium vivax is different in substrate specificity from its homologues.
Sopitthummakhun K; Maenpuen S; Yuthavong Y; Leartsakulpanich U; Chaiyen P
FEBS J; 2009 Aug; 276(15):4023-36. PubMed ID: 19549189
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
Van Voorhis WC; Rivas KL; Bendale P; Nallan L; Hornéy C; Barrett LK; Bauer KD; Smart BP; Ankala S; Hucke O; Verlinde CL; Chakrabarti D; Strickland C; Yokoyama K; Buckner FS; Hamilton AD; Williams DK; Lombardo LJ; Floyd D; Gelb MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3659-71. PubMed ID: 17606674
[TBL] [Abstract][Full Text] [Related]
15. A three-dimensional structure of Plasmodium falciparum serine hydroxymethyltransferase in complex with glycine and 5-formyl-tetrahydrofolate. Homology modeling and molecular dynamics.
França TC; Pascutti PG; Ramalho TC; Figueroa-Villar JD
Biophys Chem; 2005 May; 115(1):1-10. PubMed ID: 15848278
[TBL] [Abstract][Full Text] [Related]
16. Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria.
Kokkonda S; Deng X; White KL; El Mazouni F; White J; Shackleford DM; Katneni K; Chiu FCK; Barker H; McLaren J; Crighton E; Chen G; Angulo-Barturen I; Jimenez-Diaz MB; Ferrer S; Huertas-Valentin L; Martinez-Martinez MS; Lafuente-Monasterio MJ; Chittimalla R; Shahi SP; Wittlin S; Waterson D; Burrows JN; Matthews D; Tomchick D; Rathod PK; Palmer MJ; Charman SA; Phillips MA
J Med Chem; 2020 May; 63(9):4929-4956. PubMed ID: 32248693
[TBL] [Abstract][Full Text] [Related]
17. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents.
Krečmerová M; Dračínský M; Hocková D; Holý A; Keough DT; Guddat LW
Bioorg Med Chem; 2012 Feb; 20(3):1222-30. PubMed ID: 22249123
[TBL] [Abstract][Full Text] [Related]
19. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Dual-Stage Malaria Inhibitors with New Targets.
Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER
Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
